Late stent thrombosis in the nonbrachytherapy population: A real phenomenon?

Casserly, Ivan P.; Goldstein, Jeffrey A.; Lasala, John M.

doi:10.1002/ccd.10245

Cited by 5 publications

(2 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although early (Ͻ30 days) BMS thrombosis has been studied extensively, 10 -12 the incidence and outcome of BMS thrombosis among unselected patients in routine clinical practice during very long-term follow-up (Ͼ1 year) have been poorly characterized. 13 The long-term risk associated with BMS use among patients who would be considered off-label DES recipients is also unknown. In addition, pathological studies have identified restenosis as a mechanism that may underlie fatal late coronary stent occlusion.…”

Section: Editorial P 2363 Clinical Perspective P 2398mentioning

confidence: 99%

Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents

et al. 2007

View full text Add to dashboard Cite

Background-Concern regarding risk of late thrombosis after "off-label" treatment with drug-eluting stents has prompted increased use of bare-metal stents (BMS) in current practice. The sequelae of late BMS failures, however, have been poorly characterized. Methods and Results-We performed a retrospective study of 4503 consecutive patients treated with at least 1 BMS and dual antiplatelet therapy between 1994 and 2000. The cumulative incidence of stent thrombosis was 0.5% at 30 days (95% CI, 0.3% to 0.7%), 0.8% at 1 year (95% CI, 0.6% to 1.1%), and 2.0% at 10 years (95% CI, 1.5% to 2.5%

show abstract

Section: Editorial P 2363 Clinical Perspective P 2398mentioning

confidence: 99%

Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents

et al. 2007

View full text Add to dashboard Cite

show abstract

“…Overall incidence following bare stent implantation is < 1–2% when thienopyridine derivatives are added to aspirin therapy [1–3]. Stent thrombosis usually occurs within 1 month of implantation [2], but may occur later [2, 4–6]. Drug‐eluting stents (DES) delay stent endothelization and arterial healing [7].…”

Section: Introductionmentioning

confidence: 99%